Aaron Smargon

Title(s)Assistant Project Scientist, Cellular and Molecular Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders. RNA. 2023 04; 29(4):489-497. Morelli KH, Smargon AA, Yeo GW. PMID: 36693761; PMCID: PMC10019361.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Engineered U1 snRNAs to modulate alternatively spliced exons. Methods. 2022 09; 205:140-148. Hatch ST, Smargon AA, Yeo GW. PMID: 35764245.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    3. Crosstalk between CRISPR-Cas9 and the human transcriptome. Nat Commun. 2022 Mar 02; 13(1):1125. Smargon AA, Madrigal AA, Yee BA, Dong KD, Mueller JR, Yeo GW. PMID: 35236841; PMCID: PMC8891275.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering. Nat Cell Biol. 2020 Feb; 22(2):143-150. Smargon AA, Shi YJ, Yeo GW. PMID: 32015437; PMCID: PMC8008746.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    5. Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol. 2017 03; 15(3):169-182. Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI, Severinov K, Zhang F, Koonin EV. PMID: 28111461; PMCID: PMC5851899.
      View in: PubMed   Mentions: 402     Fields:    Translation:Cells
    6. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28. Mol Cell. 2017 Feb 16; 65(4):618-630.e7. Smargon AA, Cox DBT, Pyzocha NK, Zheng K, Slaymaker IM, Gootenberg JS, Abudayyeh OA, Essletzbichler P, Shmakov S, Makarova KS, Koonin EV, Zhang F. PMID: 28065598; PMCID: PMC5432119.
      View in: PubMed   Mentions: 238     Fields:    Translation:Cells
    7. Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. Blood Cells Mol Dis. 2007 Nov-Dec; 39(3):353-60. Lee P, Waalen J, Crain K, Smargon A, Beutler E. PMID: 17693102; PMCID: PMC2696477.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    Aaron's Networks
    Concepts (40)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department